featured
ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas
Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.